text: RT @StockRatingsHQ: Thursday, April 26th 2018 - New Buy, Sell or Hold Ratings Issued For: 
$TSPG $WU $CI $PAYX $XEL $SEGI $GT $HUN $CRM $IR‚Ä¶
time: Wed Apr 25 22:41:21 +0000 2018
text: RT @SA_BioTech: $ABBV $JNJ $NVS $GILD https://t.co/Mr59nSMlDa
time: Wed Apr 25 22:18:26 +0000 2018
text: RT @Novartis: Our Q1 2018 results are now out. Get the latest on how we‚Äôve done so far this year. $NVS
time: Wed Apr 25 22:10:56 +0000 2018
text: Risk Versus Reward: The Value of Cell Therapy for Patients and Investors: https://t.co/SAlbCOe5g5 

Maxim Group analyst Jason McCarthy exposes the companies at the forefront of the cell therapy space. #biotech #celltherapy #stocks $CYTX $BCLI $SLDB $ONCE $CELG $GILD $NVS https://t.co/0l61JfskoL
time: Wed Apr 25 21:50:05 +0000 2018
text: RT @FiercePharma: In a pharma first, $NVS cuts deal to market digital therapeutics https://t.co/MWwuhi0ros
time: Wed Apr 25 21:36:08 +0000 2018
text: Takeda has reached a preliminary deal to acquire Shire in a $64 billion pact. $TKPYY $AMGN $NVS #fda #medicare #pharma #marketers https://t.co/bE80yDC3Gu https://t.co/m2ZcW3rAUT
time: Wed Apr 25 21:30:01 +0000 2018
text: RT @FiercePharma: In a pharma first, $NVS cuts deal to market digital therapeutics https://t.co/MWwuhi0ros
time: Wed Apr 25 21:25:22 +0000 2018
text: RT @FiercePharma: In a pharma first, $NVS cuts deal to market digital therapeutics https://t.co/MWwuhi0ros
time: Wed Apr 25 21:23:11 +0000 2018
text: RT @Jdalexander64: At $17.30 4/25/18, $SGMO has Market Cap $1.5B &amp; EV of $1.1B - it will be very interesting to see how this compares with‚Ä¶
time: Wed Apr 25 20:15:10 +0000 2018
text: At $17.30 4/25/18, $SGMO has Market Cap $1.5B &amp; EV of $1.1B - it will be very interesting to see how this compares with 4/25/19 &amp; 4/25/20, if $SGMO still independent in 2 years!  $GILD $PFE $SNY $CELG $NVS $VRTX - only one pie &amp; multiple big parties that might need a slice.
time: Wed Apr 25 20:14:31 +0000 2018
text: Also from earlier: SMA Day: AveXis Gene Therapy Creeps Forward as Biogen Drug‚Äôs Sales Slow https://t.co/BHMCD7KWas $AVXS $NVS $BIIB #AANAM
time: Wed Apr 25 19:50:57 +0000 2018
text: $RIGL deeply undervalued should move to mid-4's shortly.  $ALXN $NVS
https://t.co/n1E8DEyWp5
time: Wed Apr 25 19:50:56 +0000 2018
text: RT @megtirrell: ‚ÄúWe‚Äôve spent so much time thinking about the medicines and not enough thinking about the quantification of humanity,‚Äù $NVS‚Äô‚Ä¶
time: Wed Apr 25 19:25:06 +0000 2018
text: RT @ValuentumPharma: The Transformation of Novartis Continues $NVS

Members only: https://t.co/r291JV37zR https://t.co/UJfzjhqEBU
time: Wed Apr 25 18:42:43 +0000 2018
text: RT @EPVantage: Vantage snippet ‚Äì Icer Nucala review will hit all asthma agents $GSK $SNY $RHHBY $NVS $TEVA $AZN https://t.co/q0fS3yr0Qw
time: Wed Apr 25 18:42:28 +0000 2018
text: The Transformation of Novartis Continues $NVS

Members only: https://t.co/r291JV37zR https://t.co/UJfzjhqEBU
time: Wed Apr 25 18:39:35 +0000 2018
text: $ABBV $JNJ $NVS $GILD https://t.co/Mr59nSMlDa
time: Wed Apr 25 18:25:53 +0000 2018
text: $ABBV $JNJ $NVS $GILD https://t.co/bzqdVV6ywn
time: Wed Apr 25 18:25:52 +0000 2018
text: RT @OlympiaReport: Institutes For Biomed Novartis Buys 766,666 Shares of Novartis $NVS Stock https://t.co/qQnSBb8Uhc
time: Wed Apr 25 18:25:06 +0000 2018
text: Commented on $ABBV $NVS $GILD https://t.co/MXiPRZit1z
time: Wed Apr 25 18:14:22 +0000 2018
text: RT @Novartis: NEWS: Novartis announces strong first quarter results for 2018 https://t.co/nLMdeVy43o #NovartisNews $NVS
time: Wed Apr 25 18:04:31 +0000 2018
text: RT @StockRatingsHQ: Thursday, April 26th 2018 - New Buy, Sell or Hold Ratings Issued For: 
$TSPG $WU $CI $PAYX $XEL $SEGI $GT $HUN $CRM $IR‚Ä¶
time: Wed Apr 25 16:57:42 +0000 2018
text: RT @jq1234t: @PDRennert Often forgotten $NVS OMB157 (ofatumumab subcutaneous delivery) is well ahead of ublituximab, offering more differen‚Ä¶
time: Wed Apr 25 16:53:59 +0000 2018
text: $NVS How the respected Investor's Business Daily evaluates this sick puppy. Note all the red &amp; yellow. https://t.co/qmepFvgnGp
time: Wed Apr 25 16:53:55 +0000 2018
text: RT @FiercePharma: In a pharma first, $NVS cuts deal to market digital therapeutics https://t.co/MWwuhi0ros
time: Wed Apr 25 16:41:20 +0000 2018
text: Thursday, April 26th 2018 - New Buy, Sell or Hold Ratings Issued For: 
$TSPG $WU $CI $PAYX $XEL $SEGI $GT $HUN $CRM $IR $TCEHY $CDNS $AMGN $DAVC $LW $GS $NVS $GSK $SPN $TRQ $PTN $STSC $WSTI $BAX $FBEC
https://t.co/XeV0nsSTQ7
time: Wed Apr 25 16:14:34 +0000 2018
text: RT @FiercePharma: In a pharma first, $NVS cuts deal to market digital therapeutics https://t.co/MWwuhi0ros
time: Wed Apr 25 15:46:47 +0000 2018
text: RT @BentheFidler: SMA Day: AveXis Gene Therapy Creeps Forward As Biogen Drug‚Äôs Sales Slow https://t.co/BHMCD7KWas $BIIB $AVXS $NVS #AAN18
time: Wed Apr 25 15:36:31 +0000 2018
text: RT @FiercePharma: In a pharma first, $NVS cuts deal to market digital therapeutics https://t.co/MWwuhi0ros
time: Wed Apr 25 15:34:58 +0000 2018
text: In a pharma first, $NVS cuts deal to market digital therapeutics https://t.co/MWwuhi0ros
time: Wed Apr 25 15:21:54 +0000 2018
text: RT @MMMnews: News for #pharma #marketers to know: Wed, April 25 
-Takeda reaches preliminary deal to acquire Shire in a $64 billion pact
-A‚Ä¶
time: Wed Apr 25 15:14:01 +0000 2018
text: News for #pharma #marketers to know: Wed, April 25 
-Takeda reaches preliminary deal to acquire Shire in a $64 billion pact
-Amgen posts higher Q1 profit
-Novartis rolls out mobile #app

$TKPYY $AMGN $NVS #fda #medicare https://t.co/bE80yDC3Gu https://t.co/WtLdWBEtbX
time: Wed Apr 25 15:08:25 +0000 2018
text: RT @FierceBiotech: The tech, which was created using Apple‚Äôs ResearchKit platform, allows researchers to track disease progression by colle‚Ä¶
time: Wed Apr 25 15:00:13 +0000 2018
text: @PDRennert Often forgotten $NVS OMB157 (ofatumumab subcutaneous delivery) is well ahead of ublituximab, offering more differentiation from ocrelizumab as well.
time: Wed Apr 25 14:52:17 +0000 2018
text: Well at least $NVAX green today...  Notably respecting 200-day support 

Our $DRRX $CDMO &amp; $AEZS not shabby either 

$IBB $XBI $FBT $BIB $BBH $MRK $NVS $CELG $AMGN $GILD $SHPG $BIIB
time: Wed Apr 25 14:48:19 +0000 2018
text: RT @EPVantage: Vantage snippet ‚Äì Icer Nucala review will hit all asthma agents $GSK $SNY $RHHBY $NVS $TEVA $AZN https://t.co/q0fS3yr0Qw
time: Wed Apr 25 14:31:57 +0000 2018
text: Vantage snippet ‚Äì Icer Nucala review will hit all asthma agents $GSK $SNY $RHHBY $NVS $TEVA $AZN https://t.co/q0fS3yr0Qw
time: Wed Apr 25 14:29:27 +0000 2018
text: @AbbVie files U.S. marketing application for #plaquepsoriasis med #risankizumab #biotech #biotechnology #biopharma #pharma #healthcare #BLA #psoriasis #FDA https://t.co/C1dztNytwX $ABBV $SMPQY $CELG $AMGN $NVS $LLY $VRX $JNJ $CANF
time: Wed Apr 25 14:12:54 +0000 2018
text: Late-stage study underway for AVXS-101 in pre-symptomatic spinal muscular atrophy https://t.co/Yj0OI9rjbl $AVXS $BIIB $IONS $NVS
time: Wed Apr 25 14:00:18 +0000 2018
text: @Novartis-bound @AveXisInc posts early look at data from pivotal #SMA #genetherapy trial #biotech #biotechnology #biopharma #pharma #healthcare #clinicaltrials #clinicalresults $AVXS $NVS https://t.co/ZYctv99Oi4
time: Wed Apr 25 13:46:45 +0000 2018
text: RT @PiescheM: Interesting paper for #STING agonists ( $ADRO $NVS )

Type I interferon signaling attenuates regulatory T cell function in vi‚Ä¶
time: Wed Apr 25 13:46:44 +0000 2018
text: ‚ÄòSite-less‚Äô trials in mind, Novartis launches an app for #ophthalmology research https://t.co/HeOW0WDzkT $NVS
time: Wed Apr 25 13:35:33 +0000 2018
text: RT @pharmalot: NIH is sued over plans to award an exclusive license for a CAR-T therapy to Gilead.. read lawsuit here.. https://t.co/ra3PsY‚Ä¶
time: Wed Apr 25 13:19:33 +0000 2018
text: The tech, which was created using Apple‚Äôs ResearchKit platform, allows researchers to track disease progression by collecting real-time, self-reported data directly from patients. Novartis hopes the app will spur more participation in trials:  https://t.co/bIIN7TOEhI $NVS
time: Wed Apr 25 13:01:38 +0000 2018
text: SMA Day: AveXis Gene Therapy Creeps Forward As Biogen Drug‚Äôs Sales Slow https://t.co/BHMCD7KWas $BIIB $AVXS $NVS #AAN18
time: Wed Apr 25 12:15:23 +0000 2018
text: 31 Crypto Exchanges have since 2011 been hacked... üïµüèΩ‚Äç‚ôÇÔ∏èüïµüèΩ‚Äç‚ôÇÔ∏è

Don't get your coins stolen in the 32nd hack!

Join the #1 upcoming decentralized and safe exchange, AltcoinIO! üîí

‚ñ∂Ô∏è https://t.co/r9O3oeqx7L ‚óÄÔ∏è

$TIO | $ELI | $DRGN | $TPAY | $REAL | $AIR | $NVS https://t.co/rwSWHiPfso
time: Wed Apr 25 11:38:06 +0000 2018
text: RT @FierceBiotech: These long-term outcomes will come into play when Novartis, which is set to gain control of the gene therapy through an‚Ä¶
time: Wed Apr 25 11:02:39 +0000 2018
text: Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home $NOVN $NVS #novartis https://t.co/oGoxYdP00W https://t.co/OBiyomEuuY
time: Wed Apr 25 09:44:51 +0000 2018
text: RT @fwpharma: Novartis launches app to collect patient-reported data in studies for ophthalmic diseases https://t.co/Sz8poGqDmx $NVS
time: Wed Apr 25 09:26:13 +0000 2018
text: Novartis launches app to collect patient-reported data in studies for ophthalmic diseases https://t.co/Sz8poGqDmx $NVS
time: Wed Apr 25 09:22:24 +0000 2018
text: Institutes For Biomed Novartis Buys 766,666 Shares of Novartis $NVS Stock https://t.co/qQnSBb8Uhc
time: Wed Apr 25 08:19:52 +0000 2018
text: These long-term outcomes will come into play when Novartis, which is set to gain control of the gene therapy through an $8.7 billion deal, needs to persuade people to pay for the treatment: https://t.co/qBM9K81WY7 $NVS
time: Wed Apr 25 08:13:38 +0000 2018
text: RT @ConsumerFeed: Novartis Major Shareholder Institutes For Biomed Novartis Buys $11,499,990.00 in $NVS https://t.co/7r8Jbb5r36
time: Wed Apr 25 05:25:05 +0000 2018
text: Commented on $ABBV $NVS $GILD https://t.co/EnNXgzwWmI
time: Wed Apr 25 02:25:12 +0000 2018
text: RT @herkyleese: $nwbo booth  has been found. #asco2018 #dcvax  4800 sq ft this year.  1/2 of $bmy. Who will be this years #disruptor? #dcva‚Ä¶
time: Wed Apr 25 00:57:59 +0000 2018
text: RT @pharmalot: NIH is sued over plans to award an exclusive license for a CAR-T therapy to Gilead.. read lawsuit here.. https://t.co/ra3PsY‚Ä¶
time: Wed Apr 25 00:57:43 +0000 2018
text: RT @kjilly: In a blow for #pharma, #SupremeCourt upholds the hated #IPR #patent challenge #biotech #biopharma #biotechnology #healthcare #p‚Ä¶
time: Wed Apr 25 00:36:03 +0000 2018
text: In a blow for #pharma, #SupremeCourt upholds the hated #IPR #patent challenge #biotech #biopharma #biotechnology #healthcare #patentlaws #drugpatents #BrentSaunders #PhRMA $AGN $PFE $MRK $NVS $SNY https://t.co/7t0TIkulZL
time: Wed Apr 25 00:30:58 +0000 2018
text: Commented on $ABBV $NVS $GILD https://t.co/WcmnmS2qFO
time: Wed Apr 25 00:11:46 +0000 2018
text: RT @StockRatingsHQ: Wednesday, April 25th 2018 - New Buy, Sell or Hold Ratings Issued For: 
$TSPG $WU $CI $PAYX $XEL $SEGI $GT $HUN $CRM $I‚Ä¶
time: Tue Apr 24 23:33:39 +0000 2018
text: RT @Novartis: NEWS: Novartis announces strong first quarter results for 2018 https://t.co/nLMdeVy43o #NovartisNews $NVS
time: Tue Apr 24 21:48:05 +0000 2018
text: Commented on $ABBV $NVS $GILD https://t.co/LgrJOcOv9r
time: Tue Apr 24 20:56:34 +0000 2018
text: RT @Trading4th: Biotech stocks with May PDUFA's:
May will have plenty of opportunity for event-driven biotech trades.
*Estimated dates

$SG‚Ä¶
time: Tue Apr 24 20:39:11 +0000 2018
text: RT @Novartis: Our Q1 2018 results are now out. Get the latest on how we‚Äôve done so far this year. $NVS
time: Tue Apr 24 20:25:50 +0000 2018
text: RT @herkyleese: $nwbo booth  has been found. #asco2018 #dcvax  4800 sq ft this year.  1/2 of $bmy. Who will be this years #disruptor? #dcva‚Ä¶
time: Tue Apr 24 20:18:52 +0000 2018
text: RT @Novartis: NEWS: Novartis announces strong first quarter results for 2018 https://t.co/nLMdeVy43o #NovartisNews $NVS
time: Tue Apr 24 19:57:16 +0000 2018
text: RT @megtirrell: ‚ÄúWe‚Äôve spent so much time thinking about the medicines and not enough thinking about the quantification of humanity,‚Äù $NVS‚Äô‚Ä¶
time: Tue Apr 24 19:39:22 +0000 2018
text: RT @JacobPlieth: $NVS just confirmed to me that it filed Kymriah in Japan for both ped ALL and DLBCL $GILD $CELG cc @BLLPHD @cells_nnm
time: Tue Apr 24 19:34:57 +0000 2018
text: RT @megtirrell: ‚ÄúWe‚Äôve spent so much time thinking about the medicines and not enough thinking about the quantification of humanity,‚Äù $NVS‚Äô‚Ä¶
time: Tue Apr 24 19:21:06 +0000 2018
text: $TWTR-$30.10 - down 3.5% - EARNINGS BEFORE OPEN tomorrow! Now U Know!   $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
$WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TSCO $BBBY $RGS $TEVA $RDY $MNK $ASMB
$TCK $CC $CRBP $EXEL $HL $FNSR https://t.co/DMMnjiN4Nu
time: Tue Apr 24 19:15:11 +0000 2018
text: RT @BioPharmaDive: CAR-T ups challenges in pharma supply chain https://t.co/uNPqm9A8p0 #celltherapy $GILD $NVS
time: Tue Apr 24 18:52:13 +0000 2018
text: $BIIB $IONS $AVXS $NVS $RHHBY:

Biogen Rallies After Spinraza, Multiple Sclerosis Revenue Come In Light:

https://t.co/XtPoPCWyzu
time: Tue Apr 24 18:47:01 +0000 2018
text: RT @JacobPlieth: $NVS just confirmed to me that it filed Kymriah in Japan for both ped ALL and DLBCL $GILD $CELG cc @BLLPHD @cells_nnm
time: Tue Apr 24 18:44:14 +0000 2018
text: Biogen rallies after Spinraza, multiple sclerosis sales come in light $BIIB $RHHBY $IONS $AVXS $NVS https://t.co/SZiQiKijio
time: Tue Apr 24 18:42:50 +0000 2018
text: Short vol percent for $MRK on 2018-04-23 is 47%. https://t.co/3fSg8Keh0Q $BMY 23% $NVS 49% $AMGN 55% $GSK 48%
time: Tue Apr 24 18:36:03 +0000 2018
text: RT @herkyleese: $nwbo booth  has been found. #asco2018 #dcvax  4800 sq ft this year.  1/2 of $bmy. Who will be this years #disruptor? #dcva‚Ä¶
time: Tue Apr 24 18:09:03 +0000 2018
text: RT @JacobPlieth: $NVS just confirmed to me that it filed Kymriah in Japan for both ped ALL and DLBCL $GILD $CELG cc @BLLPHD @cells_nnm
time: Tue Apr 24 18:08:29 +0000 2018
text: @Lillypad raises sales forecasts as #diabetesdrugs outperform #biotech #biopharma #biotechnology #pharma #healthcare #earnings #guidance #Trulicity #psoriasis #Taltz $LLY $NVS $AMGN $TEVA $ALDR https://t.co/vXCX2FNPyZ via @BioPharmaDive
time: Tue Apr 24 17:43:14 +0000 2018
text: RT @JacobPlieth: $NVS just confirmed to me that it filed Kymriah in Japan for both ped ALL and DLBCL $GILD $CELG cc @BLLPHD @cells_nnm
time: Tue Apr 24 17:38:49 +0000 2018
text: RT @JacobPlieth: $NVS just confirmed to me that it filed Kymriah in Japan for both ped ALL and DLBCL $GILD $CELG cc @BLLPHD @cells_nnm
time: Tue Apr 24 17:35:32 +0000 2018
text: RT @megtirrell: ‚ÄúWe‚Äôve spent so much time thinking about the medicines and not enough thinking about the quantification of humanity,‚Äù $NVS‚Äô‚Ä¶
time: Tue Apr 24 17:28:17 +0000 2018
text: CAR-T ups challenges in pharma supply chain https://t.co/uNPqm9A8p0 #celltherapy $GILD $NVS
time: Tue Apr 24 17:05:00 +0000 2018
text: RT @JacobPlieth: $NVS just confirmed to me that it filed Kymriah in Japan for both ped ALL and DLBCL $GILD $CELG cc @BLLPHD @cells_nnm
time: Tue Apr 24 16:52:41 +0000 2018
text: RT @StockRatingsHQ: Wednesday, April 25th 2018 - New Buy, Sell or Hold Ratings Issued For: 
$TSPG $WU $CI $PAYX $XEL $SEGI $GT $HUN $CRM $I‚Ä¶
time: Tue Apr 24 16:51:30 +0000 2018
text: RT @JacobPlieth: $NVS just confirmed to me that it filed Kymriah in Japan for both ped ALL and DLBCL $GILD $CELG cc @BLLPHD @cells_nnm
time: Tue Apr 24 16:49:54 +0000 2018
text: RT @JacobPlieth: $NVS just confirmed to me that it filed Kymriah in Japan for both ped ALL and DLBCL $GILD $CELG cc @BLLPHD @cells_nnm
time: Tue Apr 24 16:45:33 +0000 2018
text: RT @JacobPlieth: $NVS just confirmed to me that it filed Kymriah in Japan for both ped ALL and DLBCL $GILD $CELG cc @BLLPHD @cells_nnm
time: Tue Apr 24 16:42:23 +0000 2018
text: $NVS just confirmed to me that it filed Kymriah in Japan for both ped ALL and DLBCL $GILD $CELG cc @BLLPHD @cells_nnm
time: Tue Apr 24 16:41:47 +0000 2018
text: $ICNB.0038-(((ALERT)))-Bellissima Prosecco-Christie Brinkley - 2 new BRANDS launching&gt; $LVNTA $ILMN $SHPG $COST $MNST $MDLZ $WFM $SBAC  $VOD $TMUS $FAST $DAL $AAL $WFM $CERN $HSIC $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS https://t.co/peYmMHL5nr
time: Tue Apr 24 16:30:22 +0000 2018
text: RT @herkyleese: $nwbo booth  has been found. #asco2018 #dcvax  4800 sq ft this year.  1/2 of $bmy. Who will be this years #disruptor? #dcva‚Ä¶
time: Tue Apr 24 15:58:02 +0000 2018
text: Wednesday, April 25th 2018 - New Buy, Sell or Hold Ratings Issued For: 
$TSPG $WU $CI $PAYX $XEL $SEGI $GT $HUN $CRM $IR $TCEHY $CDNS $AMGN $DAVC $LW $GS $NVS $GSK $SPN $TRQ $PTN $STSC $WSTI $BAX $FBEC
https://t.co/ZRqpF69MuJ
time: Tue Apr 24 15:50:35 +0000 2018
text: Restless R&amp;D #executives, and a few #FDA staffers, on the move to rival pharmas #biotech #biopharma #biotechnology #pharma #healthcare #bigpharma #managementchanges #hiring #RoivantSciences $GILD $NVS $GSK $AZN $RHHBY https://t.co/sN2FF7aobh
time: Tue Apr 24 15:35:17 +0000 2018
text: RT @Novartis: Our Q1 2018 results are now out. Get the latest on how we‚Äôve done so far this year. $NVS
time: Tue Apr 24 15:30:50 +0000 2018
text: .@cityofhope solidified as a leader in #cancer immunotherapy with certification to provide patients with @novartis' Kymriah, making it the only institution in Southern California to offer both FDA-approved #CARTcell therapies. https://t.co/ji5gDuUGPc #client $CYRX $NVS $GILD
time: Tue Apr 24 15:00:47 +0000 2018
text: Interesting paper for #STING agonists ( $ADRO $NVS )

Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment https://t.co/KPwyoho3Jx #immunotherapy #cancer
time: Tue Apr 24 14:56:43 +0000 2018
text: Longtime @Sanofi R&amp;D chief Elias Zerhouni is on his way out, handing the research reins to @Roche vet John Reed - #biotech #biopharma #biotechnology #pharma #healthcare #hiring #managementchanges $SNY $RHHBY $LLY $NVS $GSK $GENZ $ALNY $BIVV https://t.co/URn9NGO2ag
time: Tue Apr 24 14:13:06 +0000 2018
text: RT @Novartis: Our Q1 2018 results are now out. Get the latest on how we‚Äôve done so far this year. $NVS
time: Tue Apr 24 13:54:02 +0000 2018
text: Wow is $CDMO is on a roll... 

Excellent update - worth a read 

$IBB $XBI $FBT $BIB $MRK $NVS $BBH $CELG $GILD $AMGN $SHPG $BIIB $DRRX $NVAX $DFFN

#biotech #CDMO @GuyAdami @jonnajarian @BKBrianKelly @RiskReversal  https://t.co/MW9zFKvUH1
time: Tue Apr 24 13:51:02 +0000 2018
text: RT @herkyleese: $nwbo booth  has been found. #asco2018 #dcvax  4800 sq ft this year.  1/2 of $bmy. Who will be this years #disruptor? #dcva‚Ä¶
time: Tue Apr 24 13:42:54 +0000 2018
text: RT @megtirrell: ‚ÄúWe‚Äôve spent so much time thinking about the medicines and not enough thinking about the quantification of humanity,‚Äù $NVS‚Äô‚Ä¶
time: Tue Apr 24 13:40:59 +0000 2018
